ERα directly activated the MDR1 transcription to increase paclitaxel-resistance of ERα-positive breast cancer cells in vitro and in vivo

International Journal of Biochemistry and Cell Biology

Volumn 53, Issue , 2014, Pages 35-45

  Shi, Jun Feng ^a   Yang, Nan ^a   Ding, Hai Jian ^a   Zhang, Jie Xin ^a   Hu, Mei Ling ^a   Leng, Yan ^a   Han, Xiao ^a   Sun, Yu Jie ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Chemotherapy resistance; ER ; MDR1; Paclitaxel

Indexed keywords

ESTROGEN RECEPTOR ALPHA; FULVESTRANT; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; RHODAMINE 123; TRANSCRIPTION FACTOR SP1; ABCB1 PROTEIN, HUMAN; ESTROGEN RECEPTOR ALPHA, HUMAN; MULTIDRUG RESISTANCE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER RESISTANCE; CANCER SIZE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MCF 7 CELL LINE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; ANIMAL; BREAST NEOPLASMS; DRUG RESISTANCE; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MCF-7 CELLS; MICE; P-GLYCOPROTEINS; PACLITAXEL; TRANSCRIPTION, GENETIC;

EID: 84901287845     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2014.04.016     Document Type: Article

References (43)

1. I. Barone, L. Brusco, and S.A. Fuqua Estrogen receptor mutations and changes in downstream gene expression and signaling Clin Cancer Res 16 2010 2702 2708
2. P. Borst, and R.O. Elferink Mammalian ABC transporters in health and disease Annu Rev Biochem 71 2002 537 592 (Pubitemid 34800230)
3. F. Cardoso, N. Harbeck, L. Fallowfield, S. Kyriakides, and E. Senkus Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 23 Suppl. 7 2012 vii11 vii19
4. J. Chang, M. Sui, and W. Fan Estrogen receptor alpha attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors Breast Cancer Res Treat 134 2012 969 980
5. K.G. Chen, and B.I. Sikic Molecular pathways: regulation and therapeutic implications of multidrug resistance Clin Cancer Res 18 2012 1863 1869
6. N.A. Colabufo, F. Berardi, M.G. Perrone, E. Capparelli, M. Cantore, and C. Inglese et al. Substrates, inhibitors and activators of P-glycoprotein: candidates for radiolabeling and imaging perspectives Curr Top Med Chem 10 2010 1703 1714
7. M. Colleoni, V. Bagnardi, N. Rotmensz, R.D. Gelber, G. Viale, and G. Pruneri et al. Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy Breast Cancer Res Treat 116 2009 359 369
8. M.M. Cornwell, and D.E. Smith SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity J Biol Chem 268 1993 19505 19511 (Pubitemid 23270733)
9. S. Ding, X. Qiao, G.L. Kucera, and U. Bierbach Design of a platinum-acridine-endoxifen conjugate targeted at hormone-dependent breast cancer Chem Commun (Camb) 49 2013 2415 2417
10. S. Dong, Z. Zhang, and H. Takahara Estrogen-enhanced peptidylarginine deiminase type IV gene (PADI4) expression in MCF-7 cells is mediated by estrogen receptor-alpha-promoted transfactors activator protein-1, nuclear factor-Y and Sp1 Mol Endocrinol 21 2007 1617 1629 (Pubitemid 47001086)
11. M.J. Duffy Estrogen receptors: role in breast cancer Crit Rev Clin Lab Sci 43 2006 325 347
12. S.P. Gampenrieder, G. Rinnerthaler, and R. Greil Neoadjuvant chemotherapy and targeted therapy in breast cancer: past, present, and future J Oncol 2013 2013 732047
13. M.M. Gottesman Mechanisms of cancer drug resistance Annu Rev Med 53 2002 615 627 (Pubitemid 34177898)
14. M. Honorat, A. Mesnier, J. Vendrell, J. Guitton, I. Bieche, and R. Lidereau et al. ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor alpha expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells Endocr Relat Cancer 15 2008 125 138 (Pubitemid 351449733)
15. H. Huo, P.G. Magro, E.C. Pietsch, B.B. Patel, and K.W. Scotto Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance Cancer Res 70 2010 8726 8735
16. W. Jin, Y. Liu, S.G. Xu, W.J. Yin, J.J. Li, and J.M. Yang et al. UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs Breast Cancer Res Treat 124 2010 39 48
17. S. Labialle, L. Gayet, E. Marthinet, D. Rigal, and L.G. Baggetto Transcriptional regulators of the human multidrug resistance 1 gene: recent views Biochem Pharmacol 64 2002 943 948 (Pubitemid 35232268)
18. Y. Maehara, Y. Emi, Y. Sakaguchi, T. Kusumoto, Y. Kakeji, and S. Kohnoe et al. Estrogen-receptor-negative breast cancer tissue is chemosensitive in vitro compared with estrogen-receptor-positive tissue Eur Surg Res 22 1990 50 55
19. C.N. Marconett, S.N. Sundar, M. Tseng, A.S. Tin, K.Q. Tran, and K.M. Mahuron et al. Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells Carcinogenesis 32 2011 1315 1323
20. C.E. Mason, F.J. Shu, C. Wang, R.M. Session, R.G. Kallen, and N. Sidell et al. Location analysis for the estrogen receptor-alpha reveals binding to diverse ERE sequences and widespread binding within repetitive DNA elements Nucleic Acids Res 38 2010 2355 2368
21. D.P. McDonnell, and J.D. Norris Connections and regulation of the human estrogen receptor Science 296 2002 1642 1644 (Pubitemid 34579150)
22. A. Mukhopadhyay, B. Deplancke, A.J. Walhout, and H.A. Tissenbaum Chromatin immunoprecipitation (ChIP) coupled to detection by quantitative real-time PCR to study transcription factor binding to DNA in Caenorhabditis elegans Nat Protoc 3 2008 698 709 (Pubitemid 351516764)
23. K. Mutoh, S. Tsukahara, J. Mitsuhashi, K. Katayama, and Y. Sugimoto Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells Cancer Sci 97 2006 1198 1204 (Pubitemid 44430645)
24. I. Plaza-Menacho, A. Morandi, D. Robertson, S. Pancholi, S. Drury, and M. Dowsett et al. Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance Oncogene 29 2010 4648 4657
25. M. Pradhan, L.A. Bembinster, S.C. Baumgarten, and J. Frasor Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements J Biol Chem 285 2010 31100 31106
26. S. Pruthi, J.C. Boughey, K.R. Brandt, A.C. Degnim, G.K. Dy, and M.P. Goetz et al. A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations Mayo Clin Proc 82 2007 1131 1140 (Pubitemid 47357147)
27. M.M. Regan, and R.D. Gelber Predicting response to systemic treatments: learning from the past to plan for the future Breast 14 2005 582 593 (Pubitemid 41683584)
28. C.S. Ross-Innes, R. Stark, A.E. Teschendorff, K.A. Holmes, H.R. Ali, and M.J. Dunning et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer Nature 481 2012 389 393
29. J.F. Shi, X.J. Li, X.X. Si, A.D. Li, H.J. Ding, and X. Han et al. ERalpha positively regulated DNMT1 expression by binding to the gene promoter region in human breast cancer MCF-7 cells Biochem Biophys Res Commun 427 2012 47 53
30. A.K. Shiau, D. Barstad, P.M. Loria, L. Cheng, P.J. Kushner, and D.A. Agard et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen Cell 95 1998 927 937 (Pubitemid 29019045)
31. M. Sui, Y. Huang, B.H. Park, N.E. Davidson, and W. Fan Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death Cancer Res 67 2007 5337 5344 (Pubitemid 46997273)
32. M. Sui, D. Jiang, C. Hinsch, and W. Fan Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine Breast Cancer Res Treat 121 2010 335 345
33. M. Sui, H. Zhang, and W. Fan The role of estrogen and estrogen receptors in chemoresistance Curr Med Chem 18 2011 4674 4683
34. R. Sundseth, G. MacDonald, J. Ting, and A.C. King DNA elements recognizing NF-Y and Sp1 regulate the human multidrug-resistance gene promoter Mol Pharmacol 51 1997 963 971 (Pubitemid 27249129)
35. Y. Tabuchi, J. Matsuoka, M. Gunduz, T. Imada, R. Ono, and M. Ito et al. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer Int J Oncol 34 2009 313 319
36. E. Tokuda, Y. Seino, A. Arakawa, M. Saito, F. Kasumi, and S. Hayashi et al. Estrogen receptor-alpha directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer Breast Cancer Res Treat 133 2012 427 436
37. C. Wang, J.A. Mayer, A. Mazumdar, K. Fertuck, H. Kim, and M. Brown et al. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor Mol Endocrinol 25 2011 1527 1538
38. O. Wesolowska Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1 Acta Biochim Pol 58 2011 433 448
39. W. Xia, T. Zhao, J. Lv, S. Xu, J. Shi, and S. Wang et al. Celecoxib enhanced the sensitivity of cancer cells to anticancer drugs by inhibition of the expression of P-glycoprotein through a COX-2-independent manner J Cell Biochem 108 2009 181 194
40. W. Ying, S. Wang, J. Shi, and Y. Sun ER-/ER+ breast cancer cell lines exhibited different resistance to paclitaxel through pulse selection Med Oncol 29 2012 495 502
41. L. Zampieri, P. Bianchi, P. Ruff, and P. Arbuthnot Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cells Anticancer Res 22 2002 2253 2259 (Pubitemid 34857050)
42. J.T. Zhang Use of arrays to investigate the contribution of ATP-binding cassette transporters to drug resistance in cancer chemotherapy and prediction of chemosensitivity Cell Res 17 2007 311 323
43. Y. Zhang, G. Zhou, H. Wang, X. Zhang, F. Wei, and Y. Cai et al. Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells Oncology 71 2006 446 455